Precision BioSciences, Inc. (DTIL) Social Stream



Precision BioSciences, Inc. (DTIL): $2.01

0.38 (+23.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DTIL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

Precision Biosciences Inc (DTIL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering DTIL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-21 5 $26 $13 $20 $3.34 498.8%
2021-11-10 5 $24 $13 $19.5 $3.34 483.83%
2021-11-11 5 $24 $13 $18.75 $3.34 461.38%
2021-12-13 4 $24 $11 $18.25 $3.34 446.41%
2022-03-16 5 $24 $11 $18.25 $3.34 446.41%
2022-03-22 5 $20 $11 $16.25 $3.34 386.53%

The Trend in the Analyst Price Target


DTIL's average price target has moved down $2.38 over the prior 45 weeks.

DTIL reports an average of 113.9% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-15 6 27 8 18.50 9.50 94.74%
2021-07-03 6 27 11 18.88 12.36 52.75%
2021-08-01 6 27 11 18.88 9.86 91.48%
2021-08-05 6 27 11 18.88 10.55 78.96%
2022-03-22 5 20 11 16.25 3.34 386.53%

DTIL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


DTIL's average broker recommendation rating improved by 0.35 over the prior 52 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DTIL as an investment opportunity.

  • In terms of how Precision Biosciences Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 575.44% of that group.
  • In the context of all US stocks, Precision Biosciences Inc's average analyst price target is greater than 124.6% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Precision Biosciences Inc's variance in analysts' estimates is lower than -350.28% of them.
  • DTIL has a higher number of analysts covering the stock than 205.82% of Healthcare stocks.

Stocks similar to Precision Biosciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DNAC, DBVT, and CYTR.

Is DTIL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4331 seconds.